Document is current

Article History

Received: 12 July 2017

Accepted: 28 October 2020

First Online: 4 November 2020

Ethics approval and consent to participate

: Ethical approval was not required since this is model-based budget impact study. Data used to compute the model were retrieved from publicly available sources listed in Tables and.

: Not applicable.

: Two authors (FR, DR) are investigators in a Research Project (PEGASUS,) funded by Genome Canada and the Canadian Institutes for Health Research (both non-for-profit organizations funded by the Canadian government). However, this RFA required some mandatory in-kind contributions from other partners. This Research Project thus receives in-kind contributions from private corporations which either offer commercial NIPT tests (Ariosa Diagnostics Inc, San Jose, CA) or offer reagents and equipment that can be used to perform NIPT assays (Life Technologies Inc, NY, USA; Illumina, San Diego, CA, USA; QIAGEN, Hilden, GER; Perkin Elmer, Waltham, MASS, USA). This funding is at arm’s length from the scientific components of the Research Project. Other authors (NL, JAB) have no conflict of interests.